CoChat

A role for the transcription factor HEY1 in glioblastoma

Open access
Hulleman, Esther, Quarto, Micaela, Vernell, Richard, Masserdotti, Giacomo, Colli, Elena, Kros, Johan M., Levi, Daniel, Gaetani, Paolo, Tunici, Patrizia, Finocchiaro, Gaetano, Baena, Riccardo Rodriguez y, Capra, Maria, Helin, Kristian · 2009 · Journal of Cellular and Molecular Medicine
Cited by 84

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Glioblastoma multiforme (GBM), the highest‐grade glioma, is the most frequent tumour of the brain with a very poor prognosis and limited therapeutic options. Although little is known about the molecular mechanisms that underlie glioblastoma formation, a number of signal transduction routes, such as the Notch and Ras signalling pathways, seem to play an important role in the formation of GBM. In the present study, we show by in situ hybridization on primary tumour material that the transcription factor HEY1, a target of the Notch signalling pathway, is specifically up‐regulated in glioma and that expression of HEY1 in GBM correlates with tumour‐grade and survival. In addition, we show by chromatin immunoprecipitations, luciferase assays and Northern blot experiments that HEY1 is a bona fide target of the E2F family of transcription factors, connecting the Ras and Notch signalling pathways. Finally, we show that ectopic expression of HEY1 induces cell proliferation in neural stem cells, while depletion of HEY1 by RNA interference reduces proliferation of glioblastoma cells in tissue culture. Together, these data imply a role for HEY1 in the progression of GBM, and therefore we propose that HEY1 may be a therapeutic target for glioblastoma patients. Moreover, HEY1 may represent a molecular marker to distinguish GBM patients with a longer survival prognosis from those at high risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2008.00307.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 84

Metadata

Authors
Hulleman, E., Quarto, M., Vernell, R., Masserdotti, G., Colli, E., Kros, J. M., Levi, D., Gaetani, P., Tunici, P., Finocchiaro, G., Baena, R. R. Y., Capra, M., & Helin, K.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2009-01
Volume
13
Issue
1
Pages
136-146
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2165130425
Cited by
84
References
7
FWCI
2.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A role for the transcription factor HEY1 in glioblastoma. https://app.cochat.ai/papers/10.1111/j.1582-4934.2008.00307.x
The paper
Hulleman, E., Quarto, M., Vernell, R., Masserdotti, G., Colli, E., Kros, J. M., Levi, D., Gaetani, P., Tunici, P., Finocchiaro, G., Baena, R. R. Y., Capra, M., & Helin, K. (2009). A role for the transcription factor HEY1 in glioblastoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2008.00307.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.